KBC Group NV Has $10.88 Million Stock Holdings in Agilent Technologies, Inc. $A

KBC Group NV grew its holdings in Agilent Technologies, Inc. (NYSE:A) by 18.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 81,883 shares of the medical research company’s stock after purchasing an additional 12,719 shares during the quarter. KBC Group NV’s holdings in Agilent Technologies were worth $10,877,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors and hedge funds also recently made changes to their positions in A. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of Agilent Technologies by 4.3% in the 4th quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 599,581 shares of the medical research company’s stock worth $82,712,000 after acquiring an additional 24,687 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its stake in Agilent Technologies by 20.9% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 53,422 shares of the medical research company’s stock valued at $7,269,000 after purchasing an additional 9,236 shares during the last quarter. Dudley & Shanley Inc. raised its stake in Agilent Technologies by 25.9% in the 2nd quarter. Dudley & Shanley Inc. now owns 69,500 shares of the medical research company’s stock valued at $9,232,000 after acquiring an additional 14,300 shares during the period. Crossmark Global Holdings Inc. grew its stake in Agilent Technologies by 39.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 33,918 shares of the medical research company’s stock valued at $4,615,000 after buying an additional 9,615 shares in the last quarter. Finally, Capricorn Fund Managers Ltd purchased a new stake in Agilent Technologies during the 1st quarter worth about $8,161,000.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on A. Sanford C. Bernstein initiated coverage on shares of Agilent Technologies in a research report on Friday, June 26th. They issued an “outperform” rating and a $155.00 price objective on the stock. Bank of America upgraded shares of Agilent Technologies from a “neutral” rating to a “buy” rating and dropped their target price for the stock from $150.00 to $145.00 in a report on Thursday, May 28th. Robert W. Baird lifted their price objective on Agilent Technologies from $155.00 to $156.00 and gave the company an “outperform” rating in a research report on Tuesday, May 26th. Royal Bank Of Canada started coverage on Agilent Technologies in a report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price target for the company. Finally, Weiss Ratings raised shares of Agilent Technologies from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, June 2nd. Two analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $160.24.

Agilent Technologies Trading Down 0.5%

Shares of NYSE:A opened at $148.55 on Friday. The business’s 50-day moving average is $135.38 and its 200 day moving average is $125.56. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27. The company has a debt-to-equity ratio of 0.43, a current ratio of 2.10 and a quick ratio of 1.62. The firm has a market capitalization of $41.95 billion, a P/E ratio of 29.83, a P/E/G ratio of 2.63 and a beta of 1.25.

Agilent Technologies (NYSE:A) last posted its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The business had revenue of $1.83 billion for the quarter, compared to analyst estimates of $1.80 billion. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the prior year, the company posted $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. On average, research analysts predict that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Wednesday, July 22nd. Shareholders of record on Tuesday, June 30th were paid a dividend of $0.255 per share. This represents a $1.02 dividend on an annualized basis and a yield of 0.7%. The ex-dividend date was Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.